Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 4/20 | 0.48 |
| ▸ | GGPS1 | O95749 | 3/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.38 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.38 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.38 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.38 |
| ▸ | GBA1 | P04062 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9161823 | 1.00 | DNM1 (0.48) | DNM1GGPS1CA12CA1CA2 | |
| SCHEMBL7920911 | 1.00 | DNM1 (0.48) | DNM1GGPS1CA12CA1CA2 | |
| SCHEMBL18941461 | 1.00 | DNM1 (0.48) | DNM1GGPS1CA12CA1CA2 | |
| Hydrochloric Acid SCHEMBL28919675 | 0.98 | DNM1 (0.50) | DNM1GGPS1CA12CA1CA2 | |
| SCHEMBL1240187 | 0.98 | DNM1 (0.44) | DNM1GGPS1CA12CA1CA2 | |
| SCHEMBL1241227 | 0.95 | DNM1 (0.42) | DNM1GGPS1CA12CA1CA2 | |
| SCHEMBL5985979 | 0.91 | DNM1 (0.35) | DNM1CA12CA1CA2CA9 | |
| SCHEMBL1403834 | 0.86 | DNM1 (0.48) | DNM1GGPS1CA12CA1CA2 | |
| Bromide SCHEMBL11679422 | 0.83 | DNM1 (0.48) | DNM1 | |
| SCHEMBL17622993 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10864478-B2 | Carbon dioxide capture system and a method of operating a carbon dioxide capture system | KABUSHIKI KAISHA TOSHIBA (JP) | 2020-12-15 | — | — | US | disclosed |
| EP-3009440-B1 | SILICONE COMPOUND HAVING A RADICAL-POLYMERIZABLE GROUP AND A METHOD FOR THE PREPARATION THEREOF | SHINETSU CHEMICAL CO (JP) | 2019-01-16 | — | — | EP | disclosed |
| US-20170165603-A1 | CARBON DIOXIDE CAPTURE SYSTEM AND A METHOD OF OPERATING A CARBON DIOXIDE CAPTURE SYSTEM | KABUSHIKI KAISHA TOSHIBA (JP) | 2017-06-15 | — | — | US | disclosed |
| EP-2784059-B1 | Method for isolating tertiary amino alcohol | TOSHIBA KK (JP) | 2016-08-24 | — | — | EP | disclosed |
| US-9181174-B2 | Method for isolating tertiary amino alcohol | KABUSHIKI KAISHA TOSHIBA (JP) | 2015-11-10 | — | — | US | disclosed |
| US-20140296576-A1 | METHOD FOR ISOLATING TERTIARY AMINO ALCOHOL | KABUSHIKI KAISHA TOSHIBA (JP) | 2014-10-02 | — | — | US | disclosed |
| EP-2784059-A1 | Method for isolating tertiary amino alcohol | Kabushiki Kaisha Toshiba (JP) | 2014-10-01 | — | — | EP | disclosed |
| EP-2291530-A1 | RECOMBINANT CELL PRODUCING 2-HYDROXYISOBUTYRIC ACID | Evonik Röhm GmbH (DE) | 2011-03-09 | — | — | EP | disclosed |
| WO-2009156214-A1 | RECOMBINANT CELL PRODUCING 2-HYDROXYISOBUTYRIC ACID | EVONIK RÖHM GMBH (DE) | 2009-12-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140296576-A1 | METHOD FOR ISOLATING TERTIARY AMINO ALCOHOL | ADH1C, AADAT, ADH1A | DNM1 1211/4885GGPS1 4836/4885CA12 3128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.